Delayed Prostate Cancer Therapy Tarrytown NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Norman Lester Rosen
(914) 965-2060
3333 Henry Hudson Way
Bronx, NY
THOMAS MOULTON, MD
(718) 579-7337
2432 Grand Concourse
Bronx, NY
Naseem Joyab Zojwalla, MD
212-305-9114
622 W 168th St PH 18-126
New York, NY
Stephen M Steinma, MR
201-302-0866
1530 Palisade Ave
Fort Lee, NJ
Andrea N leaf, MD
718-630-3691
282 Murray Ave
Larchmont, NY
Louis Juden Reed
(718) 863-8465
1180 Morris Park Ave
Bronx, NY
Steven Edward Vogl
(718) 519-7774
2220 Tiemann Ave
Bronx, NY
John Patrick Stoutenburg, MD
MHB 6-435 177 Fort Washington Ave
New York, NY
Robert S Weiner, MD
914-949-1244
150 Longview Ave
White Plains, NY
Sheryl L Leventha, MS
845-362-1750
500 New Hempstead Rd Ste C
New City, NY
Data Provided by:
    

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Hormone Therapy for Breast Cancer Tarrytown NY
Breast tenderness in women taking estrogen/progestin hormone replacement therapy could signal increased chances of developing breast cancer, a new study says. Women taking estrogen plus progestin who reported developing breast tenderness after starting the hormone therapy were 48 percent more likely to develop invasive breast cancer than women on hormone therapy who did not experience breast tenderness.
- Hormone Therapy for Lung Cancer Tarrytown NY
- Head and Neck Cancer Treatment Tarrytown NY
- Hormone Therapy for Early Prostate Cancer Tarrytown NY
- Drug Combo Proves Powerful Against Lung Cancer Tarrytown NY
- Diagnosis of Prostate Cancer Tarrytown NY
- Exercise for Prostate Cancer Tarrytown NY
- Attack Of The Cancer Fighting Tomatoes Tarrytown NY
- Hormone Therapy for Prostate Cancer Tarrytown NY
- Open Prostatectomy Versus Laparoscopic Procedure Tarrytown NY